Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome (Q43202454)

From Wikidata

Jump to navigation Jump to search

scientific article published on 5 January 2010

Language	Label	Description	Also known as
English	Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome	scientific article published on 5 January 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Michael Saletu

1

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Peter Anderer

2

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Gerda Maria Saletu-Zyhlarz

3

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Silvia Parapatics

4

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Georg Gruber

5

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Saba Nia

6

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Bernd Saletu

7

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

publication date

5 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Journal of Neural Transmission

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

117

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

463-473

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Ropinirole for restless legs syndrome: a placebo-controlled crossover trial

1 reference

https://api.crossref.org/works/10.1007%2FS00702-009-0361-3

21 January 2018

Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study

1 reference

https://api.crossref.org/works/10.1007%2FS00702-009-0361-3

21 January 2018

Treatment of idiopathic restless legs syndrome (RLS) with gabapentin

1 reference

https://api.crossref.org/works/10.1007%2FS00702-009-0361-3

21 January 2018

Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-009-0361-3

21 January 2018

Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00702-009-0361-3

21 January 2018

A randomized controlled study of pergolide in patients with restless legs syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00702-009-0361-3

21 January 2018

Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gabapentin versus Ropinirole in the Treatment of Idiopathic Restless Legs Syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Spanish version of the quality of life index: presentation and validation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The involvement of dopamine in the modulation of sleep and waking

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Planning controlled clinical trials on the basis of descriptive data analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IPEG guideline on statistical design and analysis for pharmacodynamic trials. International Pharmaco-EEG Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restless legs syndrome: a review of clinical and pathophysiologic features

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recording and scoring leg movements. The Atlas Task Force

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A scale for the objective evaluation of the state of subjective well-being as a method for longitudinal studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of restless legs syndrome with dopamine agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049491

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00702-009-0361-3

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43202454&oldid=2205867246"